tiprankstipranks
Trending News
More News >
Tissue Regenix Group PLC (GB:TRX)
LSE:TRX
UK Market

Tissue Regenix (TRX) Income Statement

Compare
16 Followers

Tissue Regenix Income Statement

Last quarter (Q2 2025), Tissue Regenix's total revenue was $13.80M, an increase of 28.17% from the same quarter last year. In Q2, Tissue Regenix's net income was $-934.00K. See Tissue Regenix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.65M$ 29.49M$ 24.48M$ 19.75M$ 12.83M
Gross Profit
$ 13.62M$ 14.04M$ 9.14M$ 5.63M$ 5.13M
Operating Expenses
$ 13.27M$ 14.43M$ 10.75M$ 8.61M$ 20.15M
Depreciation and Amortization
$ 1.05M$ 977.00K$ 971.00K$ 988.00K$ 762.00K
EBITDA
$ 1.36M$ 446.00K$ -1.04M$ -3.04M$ -9.03M
Operating Income
$ 349.00K$ -394.00K$ -2.01M$ -4.38M$ -4.12M
Other Income/Expenses
$ -913.00K$ -1.27M$ -818.00K$ -764.00K$ -6.12M
Pretax Income
$ -564.00K$ -1.67M$ -2.83M$ -5.14M$ -10.24M
Net Income
$ -713.00K$ -1.71M$ -2.69M$ -4.79M$ -9.71M
Per Share Metrics
Basic EPS
$ -0.01$ -0.02$ -0.03$ -0.07$ -0.28
Diluted EPS
$ -0.01$ -0.02$ -0.03$ -0.07$ -0.28
Weighted Average Shares Outstanding
70.60M 70.43M 70.35M 70.33M 44.48M
Weighted Average Shares Outstanding (Diluted)
70.59M 70.43M 70.35M 70.33M 44.48M
Currency in USD

Tissue Regenix Earnings and Revenue History